Target specific cross-linked heteroantibodies
US4676980A · kind A · utility
1,113Cited by
3References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 23, 1985 |
| Grant date | Jun 30, 1987 |
| Priority date | — |
| Expiry date | Sep 23, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/819
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention discloses a target specific cross-linked heteroantibody and a method of producing the same. The cross-linked heteroantibodies of the present invention can cause normal autologous cells of the immune system to destroy any unwanted cell for which an antibody is available. Treatment or control of tumors, viral infected cells, fungi, bacteria, parasites and the like is now made possible through the use of the heteroantibody complex of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.